The EMA directed Novo Nordisk to update product labels to indicate NAION as a rare side effect, defined as occurring in up to 1 in 10,000 users after at least one year of treatment
Here we show that silencing of GSTO1 with siRNA significantly impairs cancer cell viability, validating GSTO1 as a potential new target in oncology
In addition, it is suggested that the regulation of cytoskeleton and cell proliferation by the addition of glutamate induces cell differentiation of normal LECs and decreases their opacity
In a study of 122,007 people, the least fit group had a death rate five times the fittest group, and being unfit carried a mortality risk equal to or worse than smoking, diabetes, or established heart disease (Mandsager, JAMA Network Open, 2018)
The software package, MZmine, is widely (~700 citations) used for non-targeted metabolomic analysis of both human and fission yeast samples 12
10.1515/CCLM.2006.111 Clin